• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-503通过靶向胰岛素样生长因子1受体抑制骨肉瘤细胞的增殖和侵袭。

MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor.

作者信息

Wang Zili, Zheng Chenhuang, Jiang Kunqi, He Jinshen, Cao Xu, Wu Song

机构信息

Department of Orthopedics, Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.

出版信息

Exp Ther Med. 2017 Aug;14(2):1547-1553. doi: 10.3892/etm.2017.4648. Epub 2017 Jun 22.

DOI:10.3892/etm.2017.4648
PMID:28810619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5526065/
Abstract

MicroRNAs (miRs) are a class of small non-coding RNAs and have key roles in various cancer types. Recently, miR-503 has been reported to act as a tumor suppressor in osteosarcoma. However, the detailed mechanism of the regulatory role of miR-503 in osteosarcoma cell proliferation and invasion has largely remained elusive. The present study found that miR-503 was significantly downregulated in osteosarcoma tissues compared to that in matched adjacent non-tumorous tissues. In addition, the expression of miR-503 in osteosarcoma of T3-T4 stage was significantly lower when compared with that in T1-T2 stage samples. miR-503 was also downregulated in osteosarcoma cell lines (Saos-2, MG63, U2OS and SW1353), when compared with that in the normal osteoblast cell line hFOB. Overexpression of miR-503 significantly inhibited the proliferation and invasion of U2OS cells and decreased the protein levels of insulin-like growth factor 1 receptor (IGF-1R), which was further identified as a novel target of miR-503 by a luciferase reporter assay. Moreover, overexpression of IGF-1R eliminated the suppressive effects of miR-503 on the proliferation and invasion of U2OS cells, suggesting that miR-503 inhibits osteosarcoma cell proliferation and invasion by directly targeting IGF-1R. Furthermore, IGF-1R was significantly upregulated in osteosarcoma tissues compared with that in adjacent non-tumor tissues, as well as in osteosarcoma cell lines compared with that in hFOB cells. In addition, the expression levels of IGF-1R were inversely correlated to the miR-503 levels in osteosarcoma tissues, suggesting that the increased IGF-1R expression may be caused by the reduced expression of miR-503. In conclusion, the present study demonstrated that miR-503 suppresses cell proliferation and invasion in osteosarcoma via targeting IGF-1R and thus highlights the importance of miR-503/IGF-1R signaling in the malignant progression of osteosarcoma.

摘要

微小RNA(miR)是一类小的非编码RNA,在多种癌症类型中发挥关键作用。最近,有报道称miR-503在骨肉瘤中起肿瘤抑制作用。然而,miR-503在骨肉瘤细胞增殖和侵袭中调控作用的详细机制在很大程度上仍不清楚。本研究发现,与配对的相邻非肿瘤组织相比,miR-503在骨肉瘤组织中显著下调。此外,与T1-T2期样本相比,T3-T4期骨肉瘤中miR-503的表达显著降低。与正常成骨细胞系hFOB相比,miR-503在骨肉瘤细胞系(Saos-2、MG63、U2OS和SW1353)中也下调。miR-503的过表达显著抑制U2OS细胞的增殖和侵袭,并降低胰岛素样生长因子1受体(IGF-1R)的蛋白水平,荧光素酶报告基因检测进一步确定其为miR-503的一个新靶点。此外,IGF-1R的过表达消除了miR-503对U2OS细胞增殖和侵袭的抑制作用,表明miR-503通过直接靶向IGF-1R抑制骨肉瘤细胞增殖和侵袭。此外,与相邻非肿瘤组织相比,IGF-1R在骨肉瘤组织中显著上调,与hFOB细胞相比,在骨肉瘤细胞系中也显著上调。此外,骨肉瘤组织中IGF-1R的表达水平与miR-503水平呈负相关,提示IGF-1R表达增加可能是由于miR-503表达降低所致。总之,本研究表明miR-503通过靶向IGF-1R抑制骨肉瘤细胞增殖和侵袭,从而突出了miR-503/IGF-1R信号通路在骨肉瘤恶性进展中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d73/5526065/d2dbe7f580de/etm-14-02-1547-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d73/5526065/0aeaae06e0b5/etm-14-02-1547-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d73/5526065/4b0b9433b810/etm-14-02-1547-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d73/5526065/fcfafae23864/etm-14-02-1547-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d73/5526065/5935cd586d53/etm-14-02-1547-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d73/5526065/d2dbe7f580de/etm-14-02-1547-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d73/5526065/0aeaae06e0b5/etm-14-02-1547-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d73/5526065/4b0b9433b810/etm-14-02-1547-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d73/5526065/fcfafae23864/etm-14-02-1547-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d73/5526065/5935cd586d53/etm-14-02-1547-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d73/5526065/d2dbe7f580de/etm-14-02-1547-g04.jpg

相似文献

1
MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor.微小RNA-503通过靶向胰岛素样生长因子1受体抑制骨肉瘤细胞的增殖和侵袭。
Exp Ther Med. 2017 Aug;14(2):1547-1553. doi: 10.3892/etm.2017.4648. Epub 2017 Jun 22.
2
MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R.微小RNA-133a通过靶向胰岛素样生长因子-1受体抑制骨肉瘤细胞的增殖和侵袭。
Cell Physiol Biochem. 2016;38(2):598-608. doi: 10.1159/000438653. Epub 2016 Feb 5.
3
MicroRNA-30a-5p inhibits the proliferation and invasion of gastric cancer cells by targeting insulin-like growth factor 1 receptor.微小RNA-30a-5p通过靶向胰岛素样生长因子1受体抑制胃癌细胞的增殖和侵袭。
Exp Ther Med. 2017 Jul;14(1):173-180. doi: 10.3892/etm.2017.4477. Epub 2017 May 18.
4
MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.微小RNA-205通过靶向RUNX2在骨肉瘤中发挥肿瘤抑制作用。
Oncol Rep. 2016 Jun;35(6):3275-84. doi: 10.3892/or.2016.4700. Epub 2016 Mar 23.
5
MicroRNA-33b Inhibits the Proliferation and Migration of Osteosarcoma Cells via Targeting Hypoxia-Inducible Factor-1α.微小RNA-33b通过靶向缺氧诱导因子-1α抑制骨肉瘤细胞的增殖和迁移。
Oncol Res. 2017 Mar 13;25(3):397-405. doi: 10.3727/096504016X14743337535446. Epub 2016 Sep 22.
6
MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor.微小RNA-503通过抑制胰岛素样生长因子1受体来抑制肝癌细胞生长。
Onco Targets Ther. 2016 Jun 15;9:3535-44. doi: 10.2147/OTT.S106351. eCollection 2016.
7
MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells.微小RNA-93通过直接靶向骨肉瘤细胞中的P21来促进细胞增殖。
Exp Ther Med. 2017 May;13(5):2003-2011. doi: 10.3892/etm.2017.4204. Epub 2017 Mar 8.
8
MicroRNA-302a inhibits osteosarcoma cell migration and invasion by directly targeting IGF-1R.微小RNA-302a通过直接靶向胰岛素样生长因子-1受体抑制骨肉瘤细胞的迁移和侵袭。
Oncol Lett. 2018 Apr;15(4):5577-5583. doi: 10.3892/ol.2018.8049. Epub 2018 Feb 14.
9
MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS.微小RNA-101通过靶向c-FOS在骨肉瘤细胞中发挥抑制作用。
Exp Ther Med. 2016 Apr;11(4):1293-1299. doi: 10.3892/etm.2016.3085. Epub 2016 Feb 17.
10
Suppressive effect of microRNA-138 on the proliferation and invasion of osteosarcoma cells via targeting SIRT1.微小RNA-138通过靶向沉默信息调节因子1对骨肉瘤细胞增殖和侵袭的抑制作用
Exp Ther Med. 2017 Jun;13(6):3417-3423. doi: 10.3892/etm.2017.4426. Epub 2017 May 4.

引用本文的文献

1
TP53 in Biology and Treatment of Osteosarcoma.TP53在骨肉瘤生物学与治疗中的作用
Cancers (Basel). 2021 Aug 25;13(17):4284. doi: 10.3390/cancers13174284.
2
GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in Cancer.GH 和 IGF 系统:miRNAs 和 lncRNAs 在癌症中的调控作用。
Front Endocrinol (Lausanne). 2021 Aug 16;12:701246. doi: 10.3389/fendo.2021.701246. eCollection 2021.
3
The Causes and Consequences of miR-503 Dysregulation and Its Impact on Cardiovascular Disease and Cancer.miR-503失调的原因、后果及其对心血管疾病和癌症的影响

本文引用的文献

1
MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R.微小RNA-133a通过靶向胰岛素样生长因子-1受体抑制骨肉瘤细胞的增殖和侵袭。
Cell Physiol Biochem. 2016;38(2):598-608. doi: 10.1159/000438653. Epub 2016 Feb 5.
2
MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.微小RNA-503通过靶向c-myb抑制骨肉瘤的上皮-间质转化并抑制其转移。
Tumour Biol. 2016 Jul;37(7):9181-7. doi: 10.1007/s13277-016-4797-4. Epub 2016 Jan 14.
3
miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3.
Front Pharmacol. 2021 Mar 8;12:629611. doi: 10.3389/fphar.2021.629611. eCollection 2021.
4
Advances in the role of miRNAs in the occurrence and development of osteosarcoma.微小RNA在骨肉瘤发生发展中的作用研究进展
Open Med (Wars). 2020 Oct 12;15(1):1003-1011. doi: 10.1515/med-2020-0205. eCollection 2020.
5
MicroRNA-652 promotes cell proliferation and osteosarcoma invasion by directly targeting KLF9.微小RNA-652通过直接靶向KLF9促进细胞增殖和骨肉瘤侵袭。
Exp Ther Med. 2020 Oct;20(4):2953-2960. doi: 10.3892/etm.2020.9037. Epub 2020 Jul 24.
6
Mechanisms of Vasculogenic Mimicry in Ovarian Cancer.卵巢癌中血管生成拟态的机制
Front Oncol. 2019 Sep 27;9:998. doi: 10.3389/fonc.2019.00998. eCollection 2019.
7
miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2.微小RNA-491-5p通过靶向丙酮酸激酶M2抑制骨肉瘤细胞增殖。
Oncol Lett. 2018 Nov;16(5):6472-6478. doi: 10.3892/ol.2018.9451. Epub 2018 Sep 18.
8
miR‑590‑5p inhibits tumor growth in malignant melanoma by suppressing YAP1 expression.miR-590-5p 通过抑制 YAP1 表达抑制恶性黑色素瘤肿瘤生长。
Oncol Rep. 2018 Oct;40(4):2056-2066. doi: 10.3892/or.2018.6633. Epub 2018 Aug 7.
9
Insulin signaling modulates border cell movement in oogenesis.胰岛素信号调节卵发生中的边缘细胞运动。
Development. 2018 Jul 30;145(14):dev166165. doi: 10.1242/dev.166165.
微小RNA-503通过靶向E2F3抑制结肠癌细胞增殖并诱导其凋亡。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):12853-60. eCollection 2015.
4
Role of microRNA‑503 in the suppression of osteosarcoma cell proliferation and migration via modulation of fibroblast growth factor 2.微小RNA-503通过调节成纤维细胞生长因子2抑制骨肉瘤细胞增殖和迁移的作用
Mol Med Rep. 2015 Nov;12(5):7433-8. doi: 10.3892/mmr.2015.4399. Epub 2015 Sep 30.
5
RETRACTED ARTICLE: Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival.撤回文章:miR-133b/miR-503的下调作为骨肉瘤患者有效的预后和诊断因素,且这些预测生物标志物与总生存期相关。
Tumour Biol. 2015 Aug 16. doi: 10.1007/s13277-015-3918-9.
6
Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.IGF-1R表达在骨与软组织肉瘤中的预后价值:一项荟萃分析。
Onco Targets Ther. 2015 Jul 29;8:1949-55. doi: 10.2147/OTT.S88293. eCollection 2015.
7
Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.miR-503表达下调预示非小细胞肺癌患者具有晚期病理特征及不良预后。
Int J Clin Exp Pathol. 2015 May 1;8(5):5609-13. eCollection 2015.
8
Circulating cell-free miRNAs as biomarker for triple-negative breast cancer.循环游离微小RNA作为三阴性乳腺癌的生物标志物
Br J Cancer. 2015 May 26;112(11):1751-9. doi: 10.1038/bjc.2015.143. Epub 2015 Apr 23.
9
MicroRNA-503 promotes tumor progression and acts as a novel biomarker for prognosis in oesophageal cancer.微小RNA-503促进肿瘤进展,并作为食管癌预后的一种新型生物标志物。
Anticancer Res. 2015 Mar;35(3):1447-51.
10
MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM.微小RNA-503通过靶向L1细胞黏附分子在骨肉瘤中发挥肿瘤抑制作用。
PLoS One. 2014 Dec 23;9(12):e114585. doi: 10.1371/journal.pone.0114585. eCollection 2014.